Vancomycin-Resistant Enterococcus (VRE) Infection
Vancomycin-resistant Enterococci are specific types of antimicrobial-resistant bacteria that are resistant to vancomycin, the drug often used to treat infections caused by enterococci. Enteroccocci are bacteria that are normally present in the human intestines and in the female genital tract and are often found in the environment. These bacteria can sometimes cause infections. Most vancomycin-resistant Enterococci infections occur in hospitals. [Vancomycin-resistant Enterococci is also called VRE]
Resources for Patients and Healthcare Providers
- Frequently Asked Questions about VRE
- October 2008 Supplement of Infection Control and Hospital Epidemiology (Volume 29, Number S1)
FAQ's about Vancomycin-Resistant Enterococcus
8.5" by 11" flyer is available in the following formats:
Prevention
- Siegel JD, Rhinehart E, Jackson M, et al. the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, 2007
- Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006
- Guideline for Environmental Infection Control in Health-Care Facilities, 2003 [PDF - 1.4 MB]
- Hand Hygiene in Healthcare Settings, 2002
Prevention Resources for State Health Departments
- Collaboration Primer: Establishing HAI Prevention Collaboratives using ARRA Funds
- Collaboration Primer [PPT - 920 KB] available in PowerPoint format.
Monitoring VRE
CDC’s National Healthcare Safety Network Patient Safety Component includes surveillance methods to identify and track device-associated infections, such as central-line associated bloodstream infections. [More…]
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - New Hours of Operation
8am-8pm ET/Monday-Friday
Closed Holidays - cdcinfo@cdc.gov